Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute myeloid leukemia”
Clofarabine and Cytarabine in Treating Patients With Acute Myeloid Leukemia With Minimal Residual Disease
ClinicalTrials.gov study NCT00863434. IPD Sharing: Not stated. Countries: 1. Publications: 0.
S9031-S9126-S9333-S9500-B Biomarker Expression in Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01059734. IPD Sharing: Not stated. Countries: 0. Publications: 2.
BLAST MRD AML-1: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 1- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With
ClinicalTrials.gov study NCT04214249. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of LAM-003 in Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03426605. IPD Sharing: NO. Countries: 1. Publications: 0.
Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02971397. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of ASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects With FMS-like Tyrosine Kinase 3 (FLT3/ITD) Acute Myeloid Leukemia (AML) in
ClinicalTrials.gov study NCT02927262. IPD Sharing: YES. Countries: 21. Publications: 0.
Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00425477. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Investigational Immuno-therapy Study of Ulocuplumab in Combination With Low Dose Cytarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02305563. IPD Sharing: Not stated. Countries: 10. Publications: 0.
Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT01729845. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparison of Consolidation Strategies for Pediatric Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06211452. IPD Sharing: NO. Countries: 0. Publications: 11.
Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00475150. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01804101. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate Lanraplenib (LANRA) in Combination With Gilteritinib in Participants With FLT3-mutated Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05028751. IPD Sharing: NO. Countries: 2. Publications: 0.
Study of AMG 330 in Combination With Pembrolizumab in Adult With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04478695. IPD Sharing: YES. Countries: 1. Publications: 0.
Highest Dose of Uproleselan in Combination With Fludarabine and Cytarabine for Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Mixed Phenotype Acute Leukemia Relapsed or Refractory
ClinicalTrials.gov study NCT05146739. IPD Sharing: YES. Countries: 1. Publications: 0.
Vorinostat Combined With Gemtuzumab Ozogamicin, Idarubicin and Cytarabine in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01039363. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Venetoclax and Azacitidine for Non-Elderly Adult Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03573024. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01471444. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Investigating the Safety, Tolerability and Efficacy of ASP7517 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (M
ClinicalTrials.gov study NCT04079296. IPD Sharing: NO. Countries: 2. Publications: 0.
8-Chloroadenosine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02509546. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.